Clinical Trial Update: Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 study of Cx601 (darvadstrocel) for complex perianal fistulas in adults with Crohn's disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Alofisel (darvadstrocel)

Snippet

Sponsor: Takeda | Conditions: Complex Perianal Fistulas in Adult Participants With Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-10-07